SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012283
Filing Date
2016-08-12
Accepted
2016-08-12 16:17:35
Documents
68
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 512661
2 ex31-1.htm EX-31.1 27193
3 ex31-2.htm EX-31.2 24788
4 ex32-1.htm EX-32.1 7489
5 ex32-2.htm EX-32.2 7764
  Complete submission text file 0001493152-16-012283.txt   3133578

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE crbp-20160630.xml EX-101.INS 431276
7 XBRL SCHEMA FILE crbp-20160630.xsd EX-101.SCH 40100
8 XBRL CALCULATION FILE crbp-20160630_cal.xml EX-101.CAL 55532
9 XBRL DEFINITION FILE crbp-20160630_def.xml EX-101.DEF 153831
10 XBRL LABEL FILE crbp-20160630_lab.xml EX-101.LAB 290404
11 XBRL PRESENTATION FILE crbp-20160630_pre.xml EX-101.PRE 237164
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 161828456
SIC: 2834 Pharmaceutical Preparations